Risk Factors Associated with Prognosis of Progressive Stages of Acute-on-chronic Hepatitis B Liver Failure

叶佩燕,杨宗国,陈晓蓉,陆云飞

DOI: https://doi.org/10.3969/j.issn.1001-5256.2013.04.008

2013-01-01

Abstract:ObjectiveTo identify the risk factors associated with progression of acute-on-chronic liver failure (ACLF) occurring in patients with chronic hepatitis B virus (HBV) infection (CHB). MethodsThe clinical, demographic, treatment and outcome data of 180 ACLF patients with concomitant CHB managed in our hospital between June 2009 and September 2012 were retrospectively reviewed. Clinical data, taken at baseline, included markers of inflammation/infection (white blood cell (WBC) count), coagulation (prothrombin time (PT) and prothrombin activity (PTA)), and liver function (alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBil), direct bilirubin (DBil), choninesterase (CHE), albumin (Alb), globulin (Glb), total cholesterol (TC), and ammonia). In-hospital treatments included supplementation with traditional Chinese medicine-based therapies, such as Tuihuang decoction and detoxification enema. The primary outcome was survival during hospitalization. The patients were grouped for analysis according to ACLF stage (early, n=93; mid, n=61; late, n=26) and the risk factors associated with each stage were identified by using univariate (log-rank test) and multivariate (Cox’s test) regression analyses. The association of risk factors with patient survival was assessed by Kaplan-Meier curve analysis. ResultsThe three ACLF groups showed significantly different amounts of leukocytes, with the late ACLF group showing the highest WBC. The late ACLF group also showed significantly lower Glb and TC. There was a trend in reduced cumulative survival rate and shorter time to death that significantly corresponded to progressive stages of ACLF (early ACLF＞mid ACLF＞late ACLF; all P＜0.001). One-hundred-and-twenty-six (70.0%) of the patients died during their hospitalization, and multivariate regression analysis of this entire patient population identified absence of colonic enema, presence of hepatic encephalopathy, presence of hepatorenal syndrome, PTA level, TBil level, and Alb level as potential risk factors of death. The Kaplan-Meier survival analysis showed that colonic enema, hepatic encephalopathy, disease stage, WBC level, TBil level, and CHE level were associated with patient survival during the hospitalization period. ConclusionCHB patients with early ACLF have better prognosis than those with mid or late ACLF. Baseline levels of WBC, TBil, CHE, and Alb may influence a patient’s survival, regardless of ACLF stage. Supplemental treatment by colonic enema led to improved rates of survival in the ACLF patients.